These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 32614121)

  • 1. Disparities in the use of antineoplastic immunotherapy in pediatric malignant adrenal tumors.
    Shoag JM; Podda A; Kobetz EN
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28522. PubMed ID: 32614121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dinutuximab for maintenance therapy in pediatric neuroblastoma.
    McGinty L; Kolesar J
    Am J Health Syst Pharm; 2017 Apr; 74(8):563-567. PubMed ID: 28389455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
    Weiner AB; Keeter MK; Manjunath A; Meeks JJ
    Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in racial, ethnic, and healthcare disparities associated with pediatric cardiac surgery outcomes.
    Peterson JK; Chen Y; Nguyen DV; Setty SP
    Congenit Heart Dis; 2017 Jul; 12(4):520-532. PubMed ID: 28544396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
    Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
    J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
    Erbe AK; Wang W; Carmichael L; Kim K; Mendonça EA; Song Y; Hess D; Reville PK; London WB; Naranjo A; Hank JA; Diccianni MB; Reisfeld RA; Gillies SD; Matthay KK; Cohn SL; Hogarty MD; Maris JM; Park JR; Ozkaynak MF; Gilman AL; Yu AL; Sondel PM
    Clin Cancer Res; 2018 Jan; 24(1):189-196. PubMed ID: 28972044
    [No Abstract]   [Full Text] [Related]  

  • 7. Dinutuximab for the treatment of pediatric patients with neuroblastoma.
    Greenwood K; Foster JH
    Drugs Today (Barc); 2017 Sep; 53(9):469-476. PubMed ID: 29238760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NEUROBLASTOMA IN PEDIATRIC PATIENTS].
    Solovyov AE; Morgun VV; Paholchuk AP
    Klin Khir; 2015 Jun; (6):59-61. PubMed ID: 26521471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in Pediatric Oncology: An Overview of Therapy Types and Nursing Implications.
    Warren CB
    Clin J Oncol Nurs; 2018 Dec; 22(6):649-655. PubMed ID: 30452014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
    Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004-2013.
    Chen S; Tang W; Yang R; Hu X; Li Z
    Am Surg; 2020 Feb; 86(2):127-133. PubMed ID: 32167055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States.
    Verma V; Haque W; Cushman TR; Lin C; Simone CB; Chang JY; McClelland S; Welsh JW
    J Immunother; 2019; 42(2):55-64. PubMed ID: 30628924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent epidemiology of pediatric cochlear implantation in the United States: disparity among children of different ethnicity and socioeconomic status.
    Stern RE; Yueh B; Lewis C; Norton S; Sie KC
    Laryngoscope; 2005 Jan; 115(1):125-31. PubMed ID: 15630380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?
    Kehm RD; Spector LG; Poynter JN; Vock DM; Altekruse SF; Osypuk TL
    Cancer; 2018 Oct; 124(20):4090-4097. PubMed ID: 30125340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic therapy in children and adolescents].
    Kremens B
    Urologe A; 2007 Oct; 46(10):1404-6. PubMed ID: 17823786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in pediatric acute lymphoblastic leukemia.
    Inaba H; Pui CH
    Cancer Metastasis Rev; 2019 Dec; 38(4):595-610. PubMed ID: 31811553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.
    Dinh T; Truong B; Matthay KK; DuBois SG
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):108-113. PubMed ID: 27820129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
    Galli G; De Toma A; Pagani F; Randon G; Trevisan B; Prelaj A; Ferrara R; Proto C; Signorelli D; Ganzinelli M; Zilembo N; de Braud F; Garassino MC; Lo Russo G
    Lung Cancer; 2019 Nov; 137():38-42. PubMed ID: 31526910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy.
    Secola R; Marachelian A; Cohn SL; Toy B; Neville K; Granger M; Brentlinger A; Martin G
    J Pediatr Oncol Nurs; 2017; 34(3):160-172. PubMed ID: 28061552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.